XML 203 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share and Stock Plans (Tables)
12 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted earnings per share (share data presented in thousands):
 
 Year Ended March 31,
Numerator for basic and diluted earnings per share:202120202019
Net income$9,106 $59,672 $42,577 
Denominators:   
Weighted-average common stock outstanding— denominator for basic EPS23,897 23,619 23,276 
Effect of dilutive employee stock options, RSU's and performance shares276 236 384 
Adjusted weighted-average common stock outstanding and assumed conversions— denominator for diluted EPS24,173 23,855 23,660 
Schedule of Stock Options Roll Forward
A summary of option transactions during each of the three fiscal years in the period ended March 31, 2021 is as follows:
 SharesWeighted-
average
Exercise Price per share
Weighted-
average
Remaining
Contractual
Life (in years)
Aggregate
Intrinsic
Value
Outstanding at April 1, 2018922,450 21.04 7.56$13,654 
Granted133,743 38.70   
Exercised(187,907)22.09   
Cancelled(33,509)23.94   
Outstanding at March 31, 2019834,777 23.52 7.04$9,602 
Granted171,515 35.16   
Exercised(296,027)20.26   
Cancelled(183,471)31.01   
Outstanding at March 31, 2020526,794 26.53 6.93$1,518 
Granted242,178 26.74   
Exercised(97,398)20.24   
Cancelled(13,760)31.85   
Outstanding at March 31, 2021657,814 27.45 7.29$16,652 
Exercisable at March 31, 2021268,815 $24.41 5.66$7,622 
Schedule of Share-based Compensation, Stock Options, Activity The following table provides certain information with respect to stock options outstanding at March 31, 2021:
 Stock Options
Outstanding
Weighted-average
Exercise Price
Weighted-average
Remaining
Contractual Life
Range of Exercise Prices   
$10.01 to 20.0090,811 $15.26 4.92
$20.01 to 30.00322,668 $25.15 7.41
$30.01 to $40.00244,335$35.018.02
 657,814 $27.45 7.29

The following table provides certain information with respect to stock options exercisable at March 31, 2021:
Range of Exercise PricesStock Options
Exercisable
Weighted- average
Exercise Price per share
$10.01 to $20.0090,811 $15.26 
$20.01 to $30.00116,935 24.81 
$30.01 to $40.0061,069 37.25 
 268,815 $24.41 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following table provides the weighted-average assumptions used to value stock options granted during fiscal 2021, 2020, and 2019:
 Year Ended
March 31,
2021
Year Ended
March 31,
2020
Year Ended
March 31,
2019
Assumptions:   
Risk-free interest rate0.23 %2.23 %2.64 %
Dividend yield0.90 %0.68 %0.52 %
Volatility factor0.380 0.372 0.352 
Expected life5.5 years5.5 years5.5 years
Schedule of Unvested Restricted Stock Units Roll Forward
A summary of the restricted stock unit awards granted under the Company’s LTIP plan as of March 31, 2021 is as follows:
 SharesWeighted-average
Grant Date
Fair Value per share
Unvested at April 1, 2018336,789 $22.62 
Granted116,942 37.90 
Vested(211,932)22.66 
Forfeited(11,602)25.18 
Unvested at March 31, 2019230,197 $30.22 
Granted151,351 38.40 
Vested(106,792)31.90 
Forfeited(62,035)31.61 
Unvested at March 31, 2020212,721 $35.20 
Granted195,181 29.16 
Vested(125,150)31.85 
Forfeited(12,963)34.74 
Unvested at March 31, 2021269,789 $32.41 
Schedule of Nonvested Performance-based Units Activity
A summary of the performance shares transactions during each of the three fiscal years in the period ended March 31, 2021 is as follows:
SharesWeighted-average
Grant Date
Fair Value per share
Unvested at April 1, 2018126,570 $19.42 
Granted34,695 36.43 
Forfeited(7,879)22.40 
Unvested at March 31, 2019153,386 $23.11 
Granted38,585 37.67 
Forfeited(125,251)22.67 
Unvested at March 31, 202066,720 $32.36 
Granted83,164 25.97 
Vested(23,201)25.28 
Forfeited(3,451)25.28 
Unvested at March 31, 2021123,232 $29.58